Key facts
- This page summarizes William Yuan's Form 4 filing for Cure Pharmaceutical Holding Corp. (AVRW).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 27 May 2021, 19:42.
William Yuan - 07 Nov 2016 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)
- Reporting relationship
- Former Director
- Issuer ticker
- AVRW
- Reported as of
- 07 Nov 2016
- Net transaction value
- $0
- Reporting owner signature
- /s/ William Yuan
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
William Yuan filed Form 4 for Cure Pharmaceutical Holding Corp. (AVRW) on 27 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVRW
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 07 Nov 2016
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $0.7400
- Footnotes
- F1
AVRW
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 01 Jan 2019
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $3.40
- Footnotes
- F1
AVRW
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +61,654
- Change %
- Price
- $0.000000
- Shares after
- 61,654
- Date
- 23 Sep 2020
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 61,654
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
William Yuan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
Footnote F2
The reporting person received restricted stock units under the equity incentive plan. Vesting occurs within a one-year term or until the next annual meeting of shareholders. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. This late filing is due to an inadvertent administrative error and not any error of the reporting person.